Wall Street Unplugged looks beyond the regular headlines heard on mainstream

financial media to bring you unscripted interviews and breaking commentary direct from Wall Street

right to you on Main Street. How's it going out there? It's Friday, January 16th, and I'm Frank Curzia hosted a frankly speaking

podcast where I answer all your questions about the markets, stocks, economy, and anything

else you want to throw at me.

Again, this podcast was created from Wall Street Unplugged, which is on Wednesdays, because I want to

dedicate more time to answering your questions.

I said this last week, but it's the least thing I could do for more time to answering your questions.

I said this last week, but it's the least thing I could do for you.

Show my appreciation for so many of you who continue to listen to this podcast every week.

And we continue to get so many new listeners in, which is awesome.

Be sure to sending your questions at Curzio1 at gmail.com.

And let's begin with a question from Lloyd.

Lloyd says, the one stock I bought from you

is an immune therapy play called Evaxis, 80XS.

Is it not by right away since your recommendation moved the price much higher.

And I recommended these stocks, I believe in August, late August.

The way for it to come down, scale back in, my average cost is about $3.40. I sold a little bit at 7, so a little more at 9,

it may do a little bit more at 11.50. The stock has become very volatile, 10% daily moves in either direction.

Earlier this week, it suffered a bare rate. 10% daily moves in either direction.

Earlier this week it suffered a bear raid when the company announced their stage 3 trial

it created a short squeeze.

...